Inhibition of miR-181a promotes midbrain neuronal growth through a Smad1/5-dependent mechanism: implications for Parkinson’s disease

Parkinson’s disease (PD) is the second most common neurodegenerative disease, and is characterized by the progressive degeneration of nigrostriatal dopaminergic (DA) neurons. Current PD treatments are symptomatic, wear off over time and do not protect against DA neuronal loss. Finding a way to re-gr...

Full description

Saved in:
Bibliographic Details
Published in:Neuronal Signal
Main Authors: Hegarty, Shane V., Sullivan, Aideen M., O’Keeffe, Gerard W.
Format: Artigo
Language:Inglês
Published: Portland Press Ltd. 2018
Subjects:
Research Articles
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC7371012/
https://ncbi.nlm.nih.gov/pubmed/32714583
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1042/NS20170181
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items